Publication | Open Access
Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma
31
Citations
40
References
2018
Year
Our data uncover a new mechanism by which pan-HDAC inhibitors may act positively to treat patients with follicular lymphoma through the induction of the expression of plasma cell genes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1